For 6 months after renal transplant serum cholinesterase concentrations were measured in 10 patients. The value decreased in the first 15 days after operation, but was normal thereafter. Liver function tests were normal throughout the study; the cholinesterase changes were independent of immunosuppressive therapy.
In patients with chronic renal failure the serum cholinesterase concentration may vary, although it is usually in the normal range (Ryan, 1977) . Cholinesterase activity has been measured in patients who underwent renal transplant to determine if the value is affected by an improvement in renal function.
PATIENTS AND METHODS
Ten patients receiving regular haemodialysis who underwent renal transplantation were studied. The age range was 11-50 yr, and in all but two the cause of the renal disorder was known (table I) . Liver function tests were normal in all patients, and none received a blood transfusion before surgery. Serum cholinesterase concentration, dibucaine number, liver function tests and serum protein concentration were measured before and serially after operation.
Sampling and measurement of serum cholinesterase
Cholinesterase concentration was measured by the method based on benzyl choline hydrolysis (Kalow and Lindsay, 1955) . Dibucaine numbers were measured by the method of Kalow and Genest (1957) . After surgery blood was sampled between 10 and 15 days in seven patients in hospital. In three patients the sample was obtained at the first return hospital visit. Thereafter blood was sampled at approximately 2-week intervals over the next 3 months, with a final sample at 6 months after the transplant.
Anaesthetic technique
All the patients were anaesthetized using a conventional technique described previously (Ryan, 1977) . 
Management after operation
Each patient received a 60-g protein diet for 15 days and thereafter the diet was unrestricted. In every case rejection episodes occurred, and each patient received treatment between the 3rd and 5th day after operation with methyl prednisolone 1 g. Patient 3 required further treatment for rejection between days 8 and 10,
The patients were discharged from hospital approximately 3 weeks after transplantation, while receiving azothioprine 150 mg and prednisolone 40 mg daily. (Patient 9 received 75 mg and 12 mg respectively.) Fifty days after operation the dose of azothioprine was reduced to 100 mg and that of prednisolone to 35 mg per day. Prednisolone was then reduced at a rate of 5 mg for each month after this date to a final maintenance dose of 10 mg daily.
RESULTS
Nine patients were alive 6 months after transplantation. Patient 4 died 4 months after operation from a myocardial infarction. A wide range of cholinesterase activity was found before operation (0.25-1.45 u. litre" 1 ; mean 0.84 ±0.34). This finding was comparable to a previous study of patients with chronic renal failure (table II). All dibucaine numbers were normal (table I).
In the initial 15 days after surgery the cholinesterase concentration decreased in many patients, but this was not consistent and in patients 6 and 10 there was an increase (figs 1, 2). The values returned towards normal over the next 15 days; although the mean value was less than the mean before operation (P<0.01), most values were within the normal range. All values were within the normal range thereafter (Ryan, 1977 (table II) . A sharp increase in cholinesterase concentrations was found between the 84-and 184-day samples (P< 0.001), but this was not significantly different from the values before operation. Liver function tests were unchanged throughout the period of the study. The protein concentrations were normal before operation, but patient 2 had a low albumin concentration (23 g dl" 1 ) which rapidly returned to normal after operation. The protein and albumin concentrations remained normal after operation.
DISCUSSION
Cholinesterase activity before operation varied considerably between the 10 patients, who all had normal dibucaine numbers. After operation changes occurred which were often marked, but the trend, although downwards, was unpredictable in the individual. Cholinesterase activity returned to normal in about 30 days followed by a plateau effect with a sudden increase at 184 days.
Decreases in cholinesterase activity in surgical patients have been reported by Burnett and Cohen (1955) and also Zarday and others (1975) in renal transplant patients following operation. Zarday's group (1975) suggested that the decrease may have been caused by prednisolone, possibly by inhibiting glucocorticoid or protein synthesis in the liver, but azothioprine may also depress liver function (Zarday et al., 1972) . However, liver function and protein synthesis remained normal in all 10 of our patients who received both prednisolone and azothioprine. The liver is the site of cholinesterase production and improvement or decline in liver function is sensitively mirrored by serum cholinesterase changes whilst the patient is receiving full immunosuppressive treatment (Evans and Lehman, 1971) . It can be concluded that the changes in cholinesterase in this study are unrelated to liver function and reflect extracellular fluid compartment changes. The serum cholinesterase is not a sensitive guide to renal function, unlike liver function; the changes seen in this study occurred whilst a steady improvement in transplanted kidney function occurred. It is noteworthy that immunosuppressive therapy does not impair cholinesterase synthesis by the liver. The return to normal renal function is mirrored by a change in the range of values seen in haemodialysis patients to a more normal distribution.
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